Benzonatate and Hepatic failure - a phase IV clinical study of FDA data

Summary:

Hepatic failure is reported as a side effect among people who take Benzonatate (benzonatate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Metformin, and have Hepatitis c.

The phase IV clinical study analyzes which people have Hepatic failure when taking Benzonatate. It is created by eHealthMe based on reports of 16,665 people who have side effects when taking Benzonatate from the FDA, and is updated regularly.

What is Benzonatate?

Benzonatate has active ingredients of benzonatate. It is often used in cough. eHealthMe is studying from 17,274 Benzonatate users. Check the latest studies of Benzonatate.

What is Hepatic failure?

Hepatic failure (liver failure) is found to be associated with 1,539 drugs and 1,894 conditions by eHealthMe. Check the latest studies of Hepatic failure.

On Aug, 11, 2026

16,665 people reported to have side effects when taking Benzonatate.
Among them, 46 people (0.28%) have Hepatic failure.

Could Benzonatate cause Hepatic failure?

Among these 46 people:

How long have people been on Benzonatate when they have Hepatic failure? *

What is the gender of people who have Hepatic failure when taking Benzonatate? *

female: 69.77 %
male: 30.23 %

What is the age of people who have Hepatic failure when taking Benzonatate? *

What are other drugs people take besides Benzonatate? *

What are other side effects people have besides Hepatic failure? *

Acute Kidney Failure: 33 people, 71.74%
Nausea And Vomiting: 8 people, 17.39%
Dyspnea (difficult or laboured breathing): 7 people, 15.22%
Thrombocytopenia (decrease of platelets in blood): 7 people, 15.22%
Abdominal Pain: 6 people, 13.04%
Injury: 6 people, 13.04%
Renal Impairment (severely reduced kidney function): 6 people, 13.04%
Hypotension (abnormally low blood pressure): 6 people, 13.04%
Septic Shock (shock due to blood infection): 6 people, 13.04%
Pneumonia: 5 people, 10.87%

What are the existing conditions these people have? *

Hepatocellular Carcinoma (liver cancer): 3 people, 6.52%
Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 6.52%
Osteoporosis (bones weak and more likely to break): 3 people, 6.52%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 6.52%
Hepatitis C: 3 people, 6.52%
Pneumonia Bacterial (pneumonia associated with bacterial infection): 2 people, 4.35%
Asthma: 2 people, 4.35%
Lymphoma (cancer that begins in immune system cells): 2 people, 4.35%
Hyperglycemia (high blood sugar): 2 people, 4.35%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Benzonatate and have Hepatic failure?

- Check whether Hepatic failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Benzonatate:

Benzonatate (17,274 reports)

Hepatic failure treatments and more:

Hepatic failure (44,058 reports)

Browse all side effects of Benzonatate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic failure:

Hepatic failure (1,539 drugs)

Browse all the conditions that are associated with Hepatic failure:

Hepatic failure (1,894 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on benzonatate (the active ingredients of Benzonatate) and Benzonatate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.